Human Milk Oligosaccharides (HMO) Market
Report ID: SQMIG30I2309
Report ID: SQMIG30I2309
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG30I2309 |
Region:
Global |
Published Date: February, 2025
Pages:
157
|Tables:
65
|Figures:
75
Human Milk Oligosaccharides (HMO) Market size was valued at USD 229.64 Million in 2024 and is poised to grow from USD 253.3 Million in 2025 to USD 554.93 Million by 2033, growing at a CAGR of 10.3% during the forecast period (2026–2033).
The human milk oligosaccharides (HMO) market is becoming progressively more well-known as a vital element of the wellness and nutrition of infants. HMOs, or complex carbohydrates, are found naturally in human breast milk and are known to offer a variety of health advantages. These bioactive substances support the maturation of the infant's immune system, gastrointestinal health, and cognitive abilities. As our understanding of HMOs grows, there are more and more potential uses for them outside of baby nutrition, as in the fields of medicines, functional foods, and prebiotic supplements.
Growing public knowledge of HMOs' health benefits and the goal of making infant formula more like breast milk are the main factors driving market expansion. The capacity of HMOs to promote immunological and gut health is consistent with the growing trend of looking for natural and comprehensive remedies. The identification and creation of unique HMO arrangements to target distinct health advantages is another area of study attention.
However, challenges include the complexity and cost of HMO production, especially when replicating the diverse array of HMOs found in breast milk. Regulatory considerations and potential intellectual property hurdles also impact market dynamics. As HMO research continues to evolve, the market holds promise not only for infant nutrition but also for addressing various health concerns across the lifecycle. The potential to revolutionize the concept of nutrition and wellbeing underscores the significance of the HMO market in shaping the future of healthcare and functional foods.
US Human Milk Oligosaccharides (HMO) Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2026-2033
Global Market Size
USD 208.2 million
Largest Segment
2'-FL & 3-FL
Fastest Growth
2'-FL & 3-FL
Growth Rate
10.3% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Human Milk Oligosaccharides (HMO) Market is segmented by Type, Product, Application, Distribution channel and region. Based on Type, the market is segmented into 2’FL, 3’FL, 3’SL and 6’SL. Based on Product, the market is segmented into Fucosyllactose, Lnt & LNnt and Sialyllactose. Based on Application, the market is segmented into Infant formula, Functional food & beverages, Food supplements, Health ingredients for human and animal and Other. Based on Distribution channel, the market is segmented into Hypermarkets and supermarkets, Drug store or pharmacy, Mass merchandiser, Departmental stores, Mono-brand stores, Specialty stores and Online sales channel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
In human milk oligosaccharides (HMOs), the segment dominated by “2'-FL (2'-Fucosyllactose) and 3-FL (3-Fucosyllactose)” dominating the market. These HMOs are naturally abundant in human breast milk and have been extensively studied for their prebiotic and immune-supporting properties. The dominance of 2'-FL and 3-FL is attributed to their prevalence in breast milk and their potential to promote a healthy gut microbiome and contribute to infant immune development.
Simultaneously, the Sialyllactose segment is witnessing rapid growth and is considered the fastest-growing segment in the HMO market. Sialyllactose plays a crucial role in supporting brain development and cognitive function, making it an area of significant research interest. As scientific understanding advances, the demand for Sialyllactose-based products in infant formula and functional foods is on the rise, contributing to the segment's rapid growth.
Within the category of human milk oligosaccharides (HMOs), the "Infant Formula" sector is the most prevalent. In order to support a newborn's general growth, immune system development, and gastrointestinal health, infant formula manufacturers are looking for HMOs that can replicate the positive effects of natural breast milk. The rising popularity of infant formula that contains HMOs is a major factor in the expansion of the HMO industry, as more parents are looking for the best nutrition possible for their infants.
In addition, the "Functional Food & Beverages" category is showing the fastest rate of growth. Beyond newborn nutrition, adult consumers seeking out functional foods that boost immunity and intestinal health are becoming more aware of the health benefits of HMOs. The potential for incorporating HMOs into a variety of functional foods and beverages is promising as research on their many health-promoting qualities continues to be discovered. The functional food and beverage industry is poised for strong growth within the HMO market, as consumers demonstrate an increasing interest in natural ingredients and holistic well-being.
To get detailed segments analysis, Request a Free Sample Report
The human milk oligosaccharides (HMO) market showed notable regional variations, with North America having the largest market share. North America's advanced baby feeding business, robust research capacity, and increasing consumer demand for HMO-fortified goods are the reasons for its dominance. The notable use of HMOs in infant formula and related products can be attributed to the region's focus on ensuring optimal infant health and development.
Europe is now the second-biggest market for HMOs, after North America. Similar emphasis on infant health and nourishment, along with a pro-active regulatory structure that encourages the entry of new ingredients into the food and beverage industry, are advantageous for the European market. The use of HMOs in baby formula and other applications has been further supported by European consumers' preference for useful and health-improving products.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Awareness of Health Benefits
Rising Demand for Infant Nutrition
Complex Production Process
Consumer Education
Request Free Customization of this report to help us to meet your business objectives.
The human milk oligosaccharides (HMO) market is very competitive, with both well-established manufacturers and creative entrants vying for market share as demand for HMO-fortified products rises. Prominent competitors include DuPont Nutrition & Biosciences, Nestlé S.A., Glycosyn LLC, Jennewein Biotechnologie GmbH, and Elicityl owing to their experience producing HMOs, their capacity for extensive research, and their established relationships in the infant nutrition and functional foods industries.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Component types team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our Global Human Milk Oligosaccharides (HMO) Market analysis; the human milk oligosaccharides (HMO) market is experiencing significant growth globally, driven by increasing awareness of HMOs' health benefits. The market spans across regions, with North America and Europe leading due to their advanced infant nutrition sectors. Segments include infant formula, functional food and beverages, and dietary supplements. The dominance of the infant formula segment stems from the demand for breast milk mimicking nutrition. The functional food and beverage segment is emerging rapidly as consumers seek natural ingredients promoting gut health and immunity. Key drivers include rising consumer demand for holistic health solutions, ongoing research unveiling diverse HMO benefits, and collaborations fostering innovation in HMO applications. As industries embrace HMOs for their potential beyond infant nutrition, the market is poised for continued expansion and innovation.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 229.64 Million |
| Market size value in 2033 | USD 554.93 Million |
| Growth Rate | 10.3% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Human Milk Oligosaccharides (HMO) Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Human Milk Oligosaccharides (HMO) Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Human Milk Oligosaccharides (HMO) Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Human Milk Oligosaccharides (HMO) Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
